Investors Sell Allergan (AGN) on Strength After Insider Selling

Olive Hawkins
December 7, 2017

Deutsche Bank maintained Allergan plc (NYSE:AGN) rating on Tuesday, August 9. (NYSE:AGN) by 4.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. Bollard Group LLC now owns 14,200 shares of the company's stock valued at $3,270,000 after buying an additional 4,200 shares in the last quarter. Institutional owners hold 85.30% stake in the company, while insiders ownership held at 0.10%. Honeywell International Inc. increased its position in Allergan by 13.6% in the second quarter. AGN's total short interest was 7.84 million shares in December as published by FINRA. Sumitomo Life Insurance Co. increased its position in Allergan by 39.0% in the third quarter. Sumitomo Life Insurance Co. now owns 15,122 shares of the company's stock worth $3,099,000 after buying an additional 4,244 shares during the period. Edgewood Management LLC now owns 4,445,924 shares of the company's stock valued at $911,192,000 after purchasing an additional 869,248 shares in the last quarter. Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance.

The stock of Allergan plc (NYSE:AGN) is a huge mover today! About 2.30M shares traded.

The consensus recommendation, according to Zacks Investment research, is 1.81.

Among 34 analysts covering National Oilwell Varco (NYSE:NOV), 10 have Buy rating, 5 Sell and 19 Hold.

AGN has been the subject of several research analyst reports. The firm has "Equal-Weight" rating by Morgan Stanley given on Wednesday, September 20. Finally, Cantor Fitzgerald reissued a "hold" rating on shares of Allergan in a report on Tuesday, August 29th. Mizuho restated a "buy" rating and set a $275.00 price target (up previously from $273.00) on shares of Allergan plc in a research report on Tuesday, February 7th. The Massachusetts-based & Mngmt has invested 0% in Allergan plc (NYSE:AGN). Cowen & Co has "Buy" rating and $400.0 target. FCF quality is calculated as the 12 ltm cash flow per share over the average of the cash flow numbers. Volume is the basic fuel of the market since stocks move up or down in price only when shares are trading hands. The disclosure for this sale can be found here. LLC now owns 500 shares of the company's stock worth $122,000 after purchasing an additional 385 shares in the last quarter. In general, companies with the lowest combined rank may be the higher quality picks.

Ladbrokes Coral in £3.9bn takeover talks with rival GVC
Ladbrokes Coral and GVC Holding said that Thursday's announcement does not amount to a firm intention to make an official offer. Kenneth Alexander, chief executive of GVC, will take the helm on the merged company if a deal goes ahead.

Porn star August Ames found dead days after backslash for homophobic remarks
After posting her statements on Twitter, Ames was hit with a barrage of comments accusing her of being homophobic . She became the 9th most popular porn star online after her videos on Pornhub were getting most-views each day.

Blackwater founder Erik Prince details meeting with Russian in Seychelles
Prince said Bannon vouched for MBZ during the conversation, calling him "a great guy". "That's all I recall of that conversation". The meeting apparently lasted less than 30 minutes, enough time for Prince to drink one beer.

The stock 5.26% or $0 during the last trading session, reaching $0.09. Peloton Wealth Strategists now owns 10,485 shares of the company's stock worth $2,149,000 after buying an additional 2,835 shares during the period. The stock has a beta value of 1.12. The company has market cap of $55.93 billion. Rech And Company has invested 0% in Allergan plc (NYSE:AGN). The company reported $3.35 EPS for the quarter, topping the consensus estimate of $3.32 by $0.03. Allergan had a positive return on equity of 8.00% and a negative net margin of 47.27%. CLEARBRIDGE INVESTMENTS, LLC also announced decreased position in Allergan plc (AGN) during the quarter. During the same period in the prior year, the company earned $3.32 EPS.

We can also take a look at some stock volatility data on shares of Allergan plc (NYSE:AGN).

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 15th. Shareholders of record on Friday, November 17th will be given a $0.70 dividend. The ex-dividend date of this dividend is Thursday, November 16th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.70%. The 12 month volatility is now 23.736800. The company was downgraded on Monday, April 18 by Piper Jaffray. This buyback authorization allows the company to purchase up to 2.8% of its stock through open market purchases. Shares repurchase programs are usually a sign that the company's board of directors believes its shares are undervalued. "(AGN) Holdings Raised by Roosevelt Investment Group Inc." was reported by StockNewsTimes and is the sole property of of StockNewsTimes.

Allergan plc, a specialty pharmaceutical company, develops, makes, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide.

Other reports by

Discuss This Article